FDA Gives Green Light to Emergent BioSolutions to Resume COVID-19 Vaccine Manufacturing

Emergent BioSolutions is being allowed to restart manufacturing operations for the J&J COVID-19 vaccine at its Bayview, Baltimore, Md., facility.